ERNA – eterna therapeutics inc. (US:NASDAQ)
Stock Stats
News
Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate's (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models [Yahoo! Finance]
Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models
Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program [Yahoo! Finance]
Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program
Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing [Yahoo! Finance]
Form 424B3 Eterna Therapeutics Inc.
Form 424B3 Eterna Therapeutics Inc.
Form 424B3 Eterna Therapeutics Inc.
Form EFFECT Eterna Therapeutics Inc.
Form D Eterna Therapeutics Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.